In the first stage, a total of 4,68,650 docking solutions obtained from Molecular docking of approved 1735 drug molecules against 27 COVID19 proteins. From Autodock Vina output, one best pose was extracted from out of 10 poses in the second stage and 46,865 pose data utilized for further analysis (Table ). In stage three screening step, the top 20 drug molecules based on binding energy were separated for each COVID19 Protein. Which lead to 540 drugs with a potential range of docking scores (Table & 2, Figure ). The redundant drugs removed with the merger of the top 20 dock score for all COVID19 protein together yields 133 unique drugs from the 540 drugs (Supplementary material). All the 133 drugs were manually inspected for pharmacological activity reported in Drugbank. Consequently, 18 anticancer drugs, 6 anti-inflammatory, 7 anti-HIV, 8 anti-HCV, 6 drugs for lung disease, 3 drugs for anti-parasitic activity, 2 anti-migraine and few other activities reported.